Commercialized artemisinin derivatives combined with colistin protect against critical Gram-negative bacterial infection

Abstract

The anti-malaria drugs artemisinin derivatives produce a synergistic antibacterial effect with colistin against Gram-negative bacteria by simultaneously inhibiting MCR-1 function and hindering flagella assembly and energy metabolism.